Context: A Lancet Public Health study finds India's antibiotic consumption has crossed an “inflection point” — overusing the stronger “watch” category antibiotics meant for resistant infections while underusing safer first-line “access” drugs — a dangerous imbalance accelerating antimicrobial resistance (AMR) nationwide.
Key Facts
- India's overall antibiotic use stands at 18.3 DDD (Defined Daily Dose) per 1,000 people/day, above the WHO-recommended optimal range of 9.9–14.7 DDD.
- “Watch” category antibiotics (reserved for more resistant infections) are used at 9.3 DDD against a recommended 6 DDD — clear overuse.
- “Access” category antibiotics (first-line, for common infections) are used at only 4.5 DDD against the level actually needed — clear underuse.
- The National Action Plan on Antimicrobial Resistance 2.0 (2025–2029) is the government's current framework addressing the problem.
Why the Imbalance Exists
- Patient demand for “quick cures,” doctors' convenience in overstretched clinical settings, and poor diagnostic access all push prescribing toward stronger drugs by default rather than by clinical necessity.
- Liberal, often unregulated antibiotic use in livestock and agriculture compounds the human-health picture — resistance doesn't stay contained within one sector.
- Weak retail-level enforcement enables over-the-counter antibiotic sales and irrational fixed-dose combinations that bypass proper prescribing altogether.
Significance
- High AMR rates threaten to make common infections untreatable, raising morbidity, mortality and healthcare costs across the country.
- Economic costs compound through lost productivity from prolonged illness and higher treatment expenses.
- AMR is inherently a One Health problem — human, animal and agricultural antibiotic use are linked, so fixing only one domain won't solve it.
Way Forward
- Build robust antimicrobial stewardship programmes in hospitals and clinics to guide evidence-based, not default, prescribing.
- Expand access to affordable, rapid diagnostics so treatment can be targeted rather than empirical broad-spectrum by default.
- Tighten enforcement against over-the-counter antibiotic sales and irrational fixed-dose combinations.
- Regulate antibiotic use in animal husbandry and agriculture as part of an integrated One Health strategy, not a separate track.
Exam Angle — Prelims & Mains
- UPSC PYQ Link (Mains 2023, GS Paper 3): "Antimicrobial resistance (AMR) poses a significant threat to global public health and food security. Discuss the challenges in combating AMR in India and suggest comprehensive strategies, including the 'One Health' approach, to mitigate this crisis." — Use the Lancet study's specific DDD data as your evidence base.
- Practice Mains Question (GS Paper 2, 15 marks, 250 words): Critically analyze the current antibiotic usage patterns in India as highlighted by recent studies, and discuss the implications of this trend for public health and the economy.
- Prelims Angle: Remember the WHO's three-tier antibiotic classification — Access, Watch, Reserve — and that DDD (Defined Daily Dose) is the standard unit for measuring drug consumption.
- Practice Prelims MCQ: With reference to the WHO classification of antibiotics and their usage in India, consider the following statements:1. “Access” antibiotics are recommended as first-line treatments for common infections.2. India's current usage of “watch” antibiotics is below WHO-recommended levels.3. A recent study found India over-relies on stronger antibiotics even as safer first-line drugs remain underused.Options: (A) 1 and 2 only | (B) 2 and 3 only | (C) 1 and 3 only | (D) 1, 2 and 3
Show answer
Answer: (C) 1 and 3 only — Statement 1 is CORRECT — “Access” drugs are the WHO's designated first-line treatments for common infections.
- Practice Prelims MCQ: With reference to the WHO classification of antibiotics and their usage in India, consider the following statements:
Statement 2 is INCORRECT — India's “watch” antibiotic use (9.3 DDD) exceeds, not falls below, the recommended 6 DDD.
Statement 3 is CORRECT — the study explicitly documents over-reliance on stronger drugs alongside underuse of first-line “access” antibiotics.